| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
40,010,000 |
| Market
Cap: |
789.00(M) |
| Last
Volume: |
1,008,943 |
Avg
Vol: |
1,006,214 |
| 52
Week Range: |
$12.64 - $30.11 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cassava Sciences is a clinical-stage biotechnology company. Co. has combined technology with insights in neurobiology to develop solutions for Alzheimer's disease and other neurodegenerative diseases. Co. has two biopharmaceutical assets under development: its primary therapeutic product candidate, called simufilam, is a treatment for Alzheimer's disease; and its primary investigational diagnostic product candidate, called SavaDx, is a way to detect the existence of Alzheimer's disease from a small sample of blood.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
48,477 |
278,477 |
| Total Buy Value |
$0 |
$0 |
$831,428 |
$6,164,449 |
| Total People Bought |
0 |
0 |
2 |
4 |
| Total Buy Transactions |
0 |
0 |
3 |
9 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Friedmann Nadav |
Chief Operating & Med. Officer |
• • – |
2008-05-01 |
4 |
B |
$6.30 |
$20,577 |
D/D |
3,267 |
208,572 |
2.81 |
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-04-02 |
4 |
AS |
$8.55 |
$213,750 |
D/D |
(25,000) |
6,975,200 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-04-01 |
4 |
AS |
$8.62 |
$215,500 |
D/D |
(25,000) |
7,000,200 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-03-17 |
4/A |
GD |
$0.00 |
$0 |
D/D |
16,000 |
7,025,200 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-03-17 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,900 |
33,901 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-03-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
17,400 |
7,023,800 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-03-04 |
4 |
AS |
$8.16 |
$204,000 |
D/D |
(25,000) |
7,041,200 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-03-03 |
4 |
AS |
$8.16 |
$204,000 |
D/D |
(25,000) |
7,066,200 |
|
- |
|
| Eastbourne Capital Management Llc/ca |
10% Owner |
– – • |
2008-02-29 |
4 |
B |
$8.76 |
$131,400 |
D/D |
15,000 |
11,075,874 |
2.45 |
- |
|
| Eastbourne Capital Management Llc/ca |
10% Owner |
– – • |
2008-02-28 |
4 |
B |
$8.89 |
$222,250 |
D/D |
25,000 |
11,060,874 |
2.45 |
- |
|
| Friedmann Nadav |
Chief Operating & Med. Officer |
• • – |
2008-02-28 |
4 |
OE |
$5.25 |
$262,500 |
D/D |
50,000 |
205,305 |
|
- |
|
| Eastbourne Capital Management Llc/ca |
10% Owner |
– – • |
2008-02-22 |
4 |
B |
$8.98 |
$89,800 |
D/D |
10,000 |
11,035,874 |
2.45 |
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-02-04 |
4 |
S |
$8.93 |
$223,250 |
D/D |
(25,000) |
7,091,200 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-02-01 |
4 |
AS |
$8.82 |
$220,500 |
D/D |
(25,000) |
7,116,200 |
|
- |
|
| Eastbourne Capital Management Llc/ca |
10% Owner |
– – • |
2008-01-30 |
4 |
B |
$8.95 |
$331,651 |
D/D |
37,056 |
11,025,874 |
2.45 |
- |
|
| Eastbourne Capital Management Llc/ca |
10% Owner |
– – • |
2008-01-29 |
4 |
B |
$9.03 |
$183,706 |
D/D |
20,344 |
10,988,818 |
2.45 |
- |
|
| Eastbourne Capital Management Llc/ca |
10% Owner |
– – • |
2008-01-22 |
4 |
B |
$8.89 |
$154,019 |
D/D |
17,325 |
10,968,474 |
2.45 |
- |
|
| Eastbourne Capital Management Llc/ca |
10% Owner |
– – • |
2008-01-17 |
4 |
B |
$9.49 |
$282,594 |
D/D |
29,700 |
10,951,149 |
2.45 |
- |
|
| Eastbourne Capital Management Llc/ca |
10% Owner |
– – • |
2008-01-16 |
4 |
B |
$9.53 |
$2,621 |
D/D |
275 |
10,921,449 |
2.37 |
- |
|
| Eastbourne Capital Management Llc/ca |
10% Owner |
– – • |
2008-01-15 |
4 |
B |
$9.63 |
$82,337 |
D/D |
8,550 |
10,921,174 |
2.45 |
- |
|
| Eastbourne Capital Management Llc/ca |
10% Owner |
– – • |
2008-01-14 |
4 |
B |
$9.75 |
$111,638 |
D/D |
11,450 |
10,912,624 |
2.45 |
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-01-03 |
4 |
AS |
$10.11 |
$252,750 |
D/D |
(25,000) |
7,141,200 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2008-01-02 |
4 |
AS |
$10.27 |
$256,750 |
D/D |
(25,000) |
7,166,200 |
|
- |
|
| Eastbourne Capital Management Llc/ca |
10% Owner |
– – • |
2007-12-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
10,901,174 |
|
- |
|
| Barbier Remi |
President and CEO |
• • • |
2007-12-04 |
4 |
AS |
$10.08 |
$252,000 |
D/D |
(25,000) |
7,191,200 |
|
- |
|
504 Records found
|
|
Page 13 of 21 |
|
|
0.17 (0.85%) 
